Stock comparison
AxoGen
AXGN$2.38BHealthcare Market cap, Sector
JEENA SIKHO LIFECARE
JSLL.NS$72.75BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
AXGN 07 JSLL.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AXGN0wins
7winsJSLL.NS
19F
B84
54D
A87
40F
A92
27F
C66
0F
B75
26F
A91
27F
A95
Side-by-side metrics
| Metric | AXGN | JSLL.NS |
|---|---|---|
| Market cap | $2.38B | $72.75B Winner |
| P/E (TTM) | Winner: - | 33.3x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | -3.4% | 39.15% Winner |
| Gross margin | 75.01% | 88.58% Winner |
| Net margin | -13.21% | 27.68% Winner |
| Revenue CAGR 5y | 15.32% | 57.81% Winner |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | Winner: 0.1x | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AXGN leads on
- P/E (TTM)-vs 33.3x+148%
- EV/EBIT-vs 24.1x+109%
- Debt / Equity0.1xvs 0.3x+69%
JSLL.NS leads on
- Net margin27.68%vs -13.21%+148%
- ROIC (TTM)39.15%vs -3.4%+109%
- Market cap$72.75Bvs $2.38B+97%
- Revenue CAGR 5y57.81%vs 15.32%+74%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.